142 related articles for article (PubMed ID: 18206364)
1. Expression of differentiation-associated gene icb-1 is estrogen-responsive in ovarian and breast cancer cell lines.
Bollmann J; Ortmann O; Treeck O
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):16-21. PubMed ID: 18206364
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells.
Konwisorz A; Springwald A; Haselberger M; Goerse R; Ortmann O; Treeck O
Endocr Relat Cancer; 2010 Mar; 17(1):147-57. PubMed ID: 19942713
[TBL] [Abstract][Full Text] [Related]
3. Expression of icb-1 gene is interferon-gamma inducible in breast and ovarian cancer cell lines and affects the IFN gamma-response of SK-OV-3 ovarian cancer cells.
Treeck O; Kindzorra I; Pauser K; Treeck L; Ortmann O
Cytokine; 2005 Nov; 32(3-4):137-42. PubMed ID: 16219472
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
7. Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.
Naragoni S; Sankella S; Harris K; Gray WG
J Cell Physiol; 2009 Jun; 219(3):584-94. PubMed ID: 19170076
[TBL] [Abstract][Full Text] [Related]
8. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
10. Silencing of the icb-1 gene inhibits the induction of differentiation-associated genes by vitamin D3 and all-trans retinoic acid in gynecological cancer cells.
Haselberger M; Springwald A; Konwisorz A; Lattrich C; Goerse R; Ortmann O; Treeck O
Int J Mol Med; 2011 Jul; 28(1):121-7. PubMed ID: 21455565
[TBL] [Abstract][Full Text] [Related]
11. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
12. icb-1 Gene counteracts growth of ovarian cancer cell lines.
Treeck O; Schüler S; Häring J; Skrzypczak M; Lattrich C; Ortmann O
Cancer Lett; 2013 Jul; 335(2):441-6. PubMed ID: 23474491
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.
O'Donnell AJ; Macleod KG; Burns DJ; Smyth JF; Langdon SP
Endocr Relat Cancer; 2005 Dec; 12(4):851-66. PubMed ID: 16322326
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.
Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D
Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748
[TBL] [Abstract][Full Text] [Related]
15. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.
Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W
J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568
[TBL] [Abstract][Full Text] [Related]
19. Cloning and functional characterization of PELP1/MNAR promoter.
Mishra SK; Balasenthil S; Nguyen D; Vadlamudi RK
Gene; 2004 Apr; 330():115-22. PubMed ID: 15087130
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
